Literature DB >> 27671720

Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.

Claudius Griesinger1, Bertrand Desprez1, Sandra Coecke1, Warren Casey2,3, Valérie Zuang4.   

Abstract

This chapter explores the concepts, processes, tools and challenges relating to the validation of alternative methods for toxicity and safety testing. In general terms, validation is the process of assessing the appropriateness and usefulness of a tool for its intended purpose. Validation is routinely used in various contexts in science, technology, the manufacturing and services sectors. It serves to assess the fitness-for-purpose of devices, systems, software up to entire methodologies. In the area of toxicity testing, validation plays an indispensable role: "alternative approaches" are increasingly replacing animal models as predictive tools and it needs to be demonstrated that these novel methods are fit for purpose. Alternative approaches include in vitro test methods, non-testing approaches such as predictive computer models up to entire testing and assessment strategies composed of method suites, data sources and decision-aiding tools. Data generated with alternative approaches are ultimately used for decision-making on public health and the protection of the environment. It is therefore essential that the underlying methods and methodologies are thoroughly characterised, assessed and transparently documented through validation studies involving impartial actors. Importantly, validation serves as a filter to ensure that only test methods able to produce data that help to address legislative requirements (e.g. EU's REACH legislation) are accepted as official testing tools and, owing to the globalisation of markets, recognised on international level (e.g. through inclusion in OECD test guidelines). Since validation creates a credible and transparent evidence base on test methods, it provides a quality stamp, supporting companies developing and marketing alternative methods and creating considerable business opportunities. Validation of alternative methods is conducted through scientific studies assessing two key hypotheses, reliability and relevance of the test method for a given purpose. Relevance encapsulates the scientific basis of the test method, its capacity to predict adverse effects in the "target system" (i.e. human health or the environment) as well as its applicability for the intended purpose. In this chapter we focus on the validation of non-animal in vitro alternative testing methods and review the concepts, challenges, processes and tools fundamental to the validation of in vitro methods intended for hazard testing of chemicals. We explore major challenges and peculiarities of validation in this area. Based on the notion that validation per se is a scientific endeavour that needs to adhere to key scientific principles, namely objectivity and appropriate choice of methodology, we examine basic aspects of study design and management, and provide illustrations of statistical approaches to describe predictive performance of validated test methods as well as their reliability.

Entities:  

Mesh:

Year:  2016        PMID: 27671720     DOI: 10.1007/978-3-319-33826-2_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  The Influence of a Xanthine-Catechin Chemical Matrix on in vitro Macrophage-Activation Triggered by Antipsychotic Ziprasidone.

Authors:  Thiago Duarte; Fernanda Barbisan; Beatriz Sadigurski Nunes da Cunha; Verônica Farina Azzolin; Bárbara Osmarin Turra; Marta Maria Medeiros Frescura Duarte; Ivo Emilio da Cruz Jung; Euler Esteves Ribeiro; Pedro Antônio do Prado-Lima; Ivana Beatrice Mânica da Cruz
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Analysis of In Vitro Cyto- and Genotoxicity of Barbatimão Extract on Human Keratinocytes and Fibroblasts.

Authors:  Neida L Pellenz; Fernanda Barbisan; Veronica F Azzolin; Thiago Duarte; Aline Bolignon; Moisés H Mastella; Cibele F Teixeira; Euler E Ribeiro; Ivana B Mânica da Cruz; Marta M M F Duarte
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

3.  Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.

Authors:  Katharina Koch; Kristina Bartmann; Julia Hartmann; Julia Kapr; Jördis Klose; Eliška Kuchovská; Melanie Pahl; Kevin Schlüppmann; Etta Zühr; Ellen Fritsche
Journal:  Front Toxicol       Date:  2022-03-02

4.  Evaluation of Human Esophageal Epithelium Permeability in Presence of Different Formulations Containing Hyaluronic Acid and Chondroitin Sulphate.

Authors:  Gaia Pellegatta; Marco Spadaccini; Laura Lamonaca; Vincenzo Craviotto; Ferdinando D'Amico; Laura Ceriotti; Marisa Meloni; Alessandro Repici
Journal:  Med Devices (Auckl)       Date:  2020-03-04

5.  Development of a prioritization method for chemical-mediated effects on steroidogenesis using an integrated statistical analysis of high-throughput H295R data.

Authors:  Derik E Haggard; R Woodrow Setzer; Richard S Judson; Katie Paul Friedman
Journal:  Regul Toxicol Pharmacol       Date:  2019-10-29       Impact factor: 3.271

Review 6.  The ascendance of microphysiological systems to solve the drug testing dilemma.

Authors:  Eva-Maria Dehne; Tobias Hasenberg; Uwe Marx
Journal:  Future Sci OA       Date:  2017-03-31

7.  In vitro prediction of clinical signs of respiratory toxicity in rats following inhalation exposure.

Authors:  E Da Silva; C Hickey; G Ellis; K S Hougaard; J B Sørli
Journal:  Curr Res Toxicol       Date:  2021-05-21

Review 8.  Strategies to apply 3Rs in preclinical testing.

Authors:  Susana B Gorzalczany; Angeles G Rodriguez Basso
Journal:  Pharmacol Res Perspect       Date:  2021-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.